Placement Announced

Quince Therapeutics placement

US$115m raised

Announced 18 May 2026 · NASDAQ: QNCX

Advisers

Quince Therapeutics

Issuer

Not disclosed

Lead managers

Legal adviser
Placement agent

Other advisers

Financial adviser
Issuer
Quince Therapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Pharma, Rare Disease

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.